| 000 | 01069 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515070738.0 | ||
| 264 | 0 | _c20070827 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0214-0934 | ||
| 024 | 7 |
_a10.1358/dnp.2007.20.3.1084644 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeber, Bernd | |
| 245 | 0 | 0 |
_aNeuroprotective effects of alpha2-adrenergic receptor agonists. _h[electronic resource] |
| 260 |
_bDrug news & perspectives _cApr 2007 |
||
| 300 |
_a149-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic Agonists _xpharmacokinetics |
| 650 | 0 | 4 | _aAdrenergic alpha-2 Receptor Agonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazolines _xpharmacokinetics |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacokinetics |
| 700 | 1 | _aSteinfath, Markus | |
| 700 | 1 | _aScholz, Jens | |
| 700 | 1 | _aBein, Berthold | |
| 773 | 0 |
_tDrug news & perspectives _gvol. 20 _gno. 3 _gp. 149-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dnp.2007.20.3.1084644 _zAvailable from publisher's website |
| 999 |
_c17063721 _d17063721 |
||